ホルモン補充療法の世界市場:製品別(エストロゲン、人間成長)、投与経路別(経口、非経口)、疾患種類別、地域別

◆英語タイトル:Hormone Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Estrogen, Human Growth), By Route Of Administration (Oral, Parenteral), By Type Of Disease, By Region, And Segment Forecasts, 2020 - 2027
◆商品コード:GV20MY053
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2020年2月17日
◆ページ数:155
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥624,750見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥729,750見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥939,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、ホルモン補充療法の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場要因・動向・範囲、製品別(エストロゲンホルモン補充療法、HGH補充療法、甲状腺ホルモン補充療法、テストステロンホルモン補充療法)分析、投与経路別(経口、非経口、経皮、その他)分析、疾患種類別(更年期障害、甲状腺機能低下症、男性性腺機能低下症、成長ホルモン欠乏症、その他)分析、地域別分析、競争分析などの構成でお届けいたします。
・調査手法・範囲
・エグゼクティブサマリー
・市場要因・動向・範囲
・ホルモン補充療法の世界市場:製品別(エストロゲンホルモン補充療法、HGH補充療法、甲状腺ホルモン補充療法、テストステロンホルモン補充療法)
・ホルモン補充療法の世界市場:投与経路別(経口、非経口、経皮、その他)
・ホルモン補充療法の世界市場:疾患種類別(更年期障害、甲状腺機能低下症、男性性腺機能低下症、成長ホルモン欠乏症、その他)
・ホルモン補充療法の世界市場:地域別
・競争分析
【レポートの概要】

The global hormone replacement therapy market size is expected to reach USD 39.6 billion by 2027, expanding at a CAGR of 7.7%, according to a new report by Grand View Research, Inc. A significant rise in the incidence rate of hormonal disorders in the newborns, adults, and elderly and populations is driving the market. The Prader-Willi syndrome (PWS) affects one in every 15,000 newborns, thereby boosting the demand for the therapy.

Estrogen replacement hormone therapy helps in reducing the vaginal indications of menopause, such as dryness, burning, itching, and pain during intercourse. Estrogen is available in the forms of pill, gel, skin patch, cream or spray form. It is highly successful for treating problematic menopausal night sweats and hot flashes. Around 45% of women between the ages of 40 to 60 years of age were reported taking counseling sessions from a physician regarding the advantages and disadvantages of using hormone replacement therapy (HRT) after menopause.

Growing awareness about menopausal signs and the treatment options is growing the HRT market. Owing to the significant development for ERT, there has been an initiation of very safe treatment options for the patients situated in various geographies of the world. For example, augmentation of innovative drug delivery systems like transdermal estrogen patches and vaginal estrogen drugs.

Further key findings from the report suggest:

• The estrogen replacement therapy segment dominated the overall market in terms of revenue share in the year 2019. On the other hand, the parenteral segment is likely to showcase the fastest growth rate over the forecast period from 2020 to 2027, owing to the rising number of hormonal disorders

• Menopause is likely to showcase the fastest growth rate over the forecast period. Women are vulnerable to certain diseases and conditions such as osteoporosis and hot flashes during and after menopause. About 73% of postmenopausal women suffer from hot flashes

• North America dominated the overall hormone replacement therapy market in terms of revenue share in the year 2019. The increase in the incidence rate of hypogonadism due to a rise in obesity and poor health in the geriatric population drive the market. According to the American Academy of Family Physicians, more than 2.5 million Americans received testosterone treatment in U.S alone in 2014

• Some of the key players in this market are Abbott Laboratories; Novartis; Pfizer, Inc.; Mylan Laboratories; Merck and Co.; Novo Nordisk; Bayer Healthcare; Eli Lilly; and Genentech.

【レポートの目次】

Table of Contents

Chapter Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Route of Administration
1.1.3 Type of Disease
1.1.4 Regional Scope
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis (Model 1)
1.6.2 Volume price analysis (Model 2)
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective – 1
1.8.2 Objective – 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Product
2.2.2 Route of Administration
2.2.3 Type of Disease
2.2.4 Region
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Penetration & Growth Prospect Mapping
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 Hormone Replacement Therapy Market: Business Environment Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Bargaining power of suppliers
3.3.1.2 Bargaining power of buyers
3.3.1.3 Threat of new entrants
3.3.1.4 Competitive rivalry
3.3.1.5 Threat of substitutes
3.3.2 PESTEL Analysis
3.3.2.1 Political & legal
3.3.2.2 Economic
3.3.2.3 Technological
Chapter 4 Hormone Replacement Therapy Market: Product Analysis
4.1 Hormone Replacement Therapy Product Market Share Analysis, 2019 & 2027
4.2 Hormone Replacement Therapy Product Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Product Segment
4.3.1 Estrogen Hormone Replacement Therapy
4.3.1.1 Estrogen Hormone replacement therapy market, 2016 – 2027 (USD Million)
4.3.2 HGH Replacement Therapy
4.3.2.1 HGH replacement therapy market, 2016 – 2027 (USD Million)
4.3.3 Thyroid Hormone Replacement Therapy
4.3.3.1 Thyroid hormone replacement therapy market, 2016 – 2027 (USD Million)
4.3.4 Testosterone Hormone Replacement Therapy
4.3.4.1 Testosterone hormone replacement therapy market, 2016 – 2027 (USD Million)
Chapter 5 Hormone Replacement Therapy Market: Route of Administration Analysis
5.1 Hormone Replacement Therapy Route of Administration Market Share Analysis, 2019 & 2027
5.2 Hormone Replacement Therapy Route of Administration Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Route of Administration Segment
5.3.1 Oral
5.3.1.1 Oral market, 2016 – 2027 (USD Million)
5.3.2 Parenteral
5.3.2.1 Parenteral market, 2016 – 2027 (USD Million)
5.3.3 Transdermal
5.3.3.1 Transdermal market, 2016 – 2027 (USD Million)
5.3.4 Others
5.3.4.1 Others market, 2016 – 2027 (USD Million)
Chapter 6 Hormone Replacement Therapy Market: Type of Disease Analysis
6.1 Hormone Replacement Therapy Type of Disease Market Share Analysis, 2019 & 2027
6.2 Hormone Replacement Therapy Type of Disease Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Type of Disease Segment
6.3.1 Menopause
6.3.1.1 Menopause market, 2016 – 2027 (USD Million)
6.3.2 Hypothyroidism
6.3.2.1 Hypothyroidism market, 2016 – 2027 (USD Million)
6.3.3 Male Hypogonadism
6.3.3.1 Male hypogonadism market, 2016 – 2027 (USD Million)
6.3.4 Growth Hormone Deficiency
6.3.4.1 Growth hormone deficiency market, 2016 – 2027 (USD Million)
6.3.5 Others
6.3.5.1 Others market, 2016 – 2027 (USD Million)
Chapter 7 Hormone Replacement Therapy Market: Regional Analysis
7.1 Hormone Replacement Therapy Regional Market Share Analysis, 2019 & 2027
7.2 Hormone Replacement Therapy Regional Market: Segment Dashboard
7.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
7.4 Market Size, & Forecasts, and Trend Analysis, 2016 to 2027
7.4.1 North America
7.4.1.1 North America hormone replacement therapy market, 2016 – 2027 (USD Million)
7.4.1.1.1 U.S.
7.4.1.1.1.1 U.S. hormone replacement therapy market, 2016 – 2027 (USD Million)
7.4.1.1.2 Canada
7.4.1.1.2.1 Canada hormone replacement therapy market, 2016 – 2027 (USD Million)
7.4.2 Europe
7.4.2.1 Europe Hormone Replacement Therapy market, 2016 – 2027 (USD Million)
7.4.2.1.1 U.K.
7.4.2.1.1.1 U.K. hormone replacement therapy market, 2016 – 2027 (USD Million)
7.4.2.1.2 Germany
7.4.2.1.2.1 Germany hormone replacement therapy market, 2016 – 2027 (USD Million)
7.4.3 Asia Pacific
7.4.3.1 Asia Pacific hormone replacement therapy market, 2016 – 2027 (USD Million)
7.4.3.1.1 Japan
7.4.3.1.1.1 Japan hormone replacement therapy market, 2016 – 2027 (USD Million)
7.4.3.1.2 China
7.4.3.1.2.1 China hormone replacement therapy market, 2016 – 2027 (USD Million)
7.4.4 Latin America
7.4.4.1 Latin America hormone replacement therapy market, 2016 – 2027 (USD Million)
7.4.4.1.1 Brazil
7.4.4.1.1.1 Brazil hormone replacement therapy market, 2016 – 2027 (USD Million)
7.4.4.1.2 Mexico
7.4.4.1.2.1 Mexico hormone replacement therapy market, 2016 – 2027 (USD Million)
7.4.5 Middle East and Africa (MEA)
7.4.5.1 MEA hormone replacement therapy market, 2016 – 2027 (USD Million)
7.4.5.1.1 South Africa
7.4.5.1.1.1 South Africa hormone replacement therapy market, 2016 – 2027 (USD Million)
7.4.5.1.2 Saudi Arabia
7.4.5.1.2.1 Saudi Arabia hormone replacement therapy market, 2016 – 2027 (USD Million)
Chapter 8 Competitive Analysis
8.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
8.2 Vendor Landscape
8.3 Company market position analysis (Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)
8.4 Company Profiles
8.4.1 Abbott Laboratories
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 Novartis
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.3 Pfizer
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.4 Mylan Laboratories
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.5 Merck & Co.
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.6 Amgen
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.7 Novo Nordisk
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.8 Bayer
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic initiatives
8.4.9 Eli Lilly
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategic initiatives
8.4.10 Genentech
8.4.10.1 Company overview
8.4.10.2 Financial performance
8.4.10.3 Product benchmarking
8.4.10.4 Strategic initiatives

List of Tables

TABLE 1 Time to market comparison between SUT and SS-based biologic manufacturing
TABLE 2 Required time for change over comparison between SUT and SS-based biologic manufacturing
TABLE 3 Output comparison between SUT and SS-based biologic manufacturing
TABLE 4 North America downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 5 North America downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 6 North America solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 7 North America concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 8 North America downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 9 U.S. downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 10 U.S. downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 11 U.S. solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 12 U.S. concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 13 U.S. downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 14 Canada downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 15 Canada downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 16 Canada solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 17 Canada concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 18 Canada downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 19 Europe downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 20 Europe downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 21 Europe solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 22 Europe concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 23 Europe downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 24 U.K. downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 25 U.K. downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 26 U.K. solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 27 U.K. concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 28 U.K. downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 29 Germany downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 30 Germany downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 31 Germany solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 32 Germany concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 33 Germany downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 34 Asia Pacific downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 35 Asia Pacific downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 36 Asia Pacific solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 37 Asia Pacific concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 38 Asia Pacific downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 39 Japan downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 40 Japan downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 41 Japan solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 42 Japan concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 43 Japan downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 44 China downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 45 China downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 46 China solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 47 China concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 48 China downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 49 India downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 50 India downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 51 India solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 52 India concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 53 India downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 54 Latin America downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 55 Latin America downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 56 Latin America solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 57 Latin America concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 58 Latin America downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 59 Brazil downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 60 Brazil downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 61 Brazil solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 62 Brazil concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 63 Brazil downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 64 Mexico downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 65 Mexico downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 66 Mexico solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 67 Mexico concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 68 Mexico downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 69 MEA downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 70 MEA downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 71 MEA solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 72 MEA concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 73 MEA downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 74 South Africa downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 75 South Africa downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 76 South Africa solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 77 South Africa concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 78 South Africa downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)
TABLE 79 UAE downstream processing market estimates & forecasts, by product, 2016 - 2027 (USD Million)
TABLE 80 UAE downstream processing market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 81 UAE solid-liquid separation market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 82 UAE concentration market estimates & forecasts, by technique, 2016 - 2027 (USD Million)
TABLE 83 UAE downstream processing market estimates & forecasts, by application, 2016 - 2027 (USD Million)


List of Figures

FIG. 1 Market snapshot
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value chain-based sizing & forecasting
FIG. 7 QFD modelling for market share assessment
FIG. 8 Downstream processing market: Parent market outlook
FIG. 9 Market trends & outlook
FIG. 10 Market segmentation & scope
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Cumulative success rate comparison of biologics with small molecules over time
FIG. 13 Number of biologics Investigational New Drugs, 2005 - 2015
FIG. 14 Key trends in biopharma manufacturing trends
FIG. 15 Capital expenditure comparison between Single-Use Technology (SUT) and Stainless Steel (SS)-based biologic manufacturing
FIG. 16 Operating expense comparison between SUT and SS-based biologic manufacturing
FIG. 17 Operating expense-labor comparison between SUT and SS-based biologic manufacturing
FIG. 18 Market restraint relevance analysis (Current & future impact)
FIG. 19 Major factors inhibiting SUT adoption
FIG. 20 Penetration & growth prospect mapping for product, 2018
FIG. 21 SWOT analysis, by factor (political & legal, economic and technological)
FIG. 22 Porter’s Five Forces Analysis
FIG. 23 Global downstream processing market: Product outlook key takeaways
FIG. 24 Global downstream processing market: Product movement analysis
FIG. 25 Global chromatography systems market, 2016 - 2027 (USD Million)
FIG. 26 Global filters market, 2016 - 2027 (USD Million)
FIG. 27 Global evaporators market, 2016 - 2027 (USD Million)
FIG. 28 Global centrifuges market, 2016 - 2027 (USD Million)
FIG. 29 Global dryers’ market, 2016 - 2027 (USD Million)
FIG. 30 Global other downstream processing products market, 2016 - 2027 (USD Million)
FIG. 31 Global downstream processing market: Technique outlook key takeaways
FIG. 32 Global downstream processing market: Technique movement analysis
FIG. 33 Global cell disruption market, 2016 - 2027 (USD Million)
FIG. 34 Global solid-liquid separation market, 2016 - 2027 (USD Million)
FIG. 35 Global filtration market, 2016 - 2027 (USD Million)
FIG. 36 Global centrifugation market, 2016 - 2027 (USD Million)
FIG. 37 Global concentration market, 2016 - 2027 (USD Million)
FIG. 38 Global evaporation market, 2016 - 2027 (USD Million)
FIG. 39 Global membrane filtration market, 2016 - 2027 (USD Million)
FIG. 40 Global purification by chromatography market, 2016 - 2027 (USD Million)
FIG. 41 Global formulation market, 2016 - 2027 (USD Million)
FIG. 42 Global downstream processing market: Application outlook key takeaways
FIG. 43 Global downstream processing market: Application movement analysis
FIG. 44 Global downstream processing market for antibiotic production, 2016 - 2027 (USD Million)
FIG. 45 Global downstream processing market for hormone production, 2016 - 2027 (USD Million)
FIG. 46 Global downstream processing market for antibodies production, 2016 - 2027 (USD Million)
FIG. 47 Global downstream processing market for enzyme production, 2016 - 2027 (USD Million)
FIG. 48 Global downstream processing market for vaccine production, 2016 - 2027 (USD Million)
FIG. 49 Regional marketplace: Key takeaway
FIG. 50 Global downstream processing market: Regional outlook, 2019 & 2027
FIG. 51 North America downstream processing market, 2016 - 2027 (USD Million)
FIG. 52 U.S. downstream processing market, 2016 - 2027 (USD Million)
FIG. 53 Canada downstream processing market, 2016 - 2027 (USD Million)
FIG. 54 Europe downstream processing market, 2016 - 2027 (USD Million)
FIG. 55 U.K. downstream processing market, 2016 - 2027 (USD Million)
FIG. 56 Germany downstream processing market, 2016 - 2027 (USD Million)
FIG. 57 Asia Pacific downstream processing market, 2016 - 2027 (USD Million)
FIG. 58 Japan downstream processing market, 2016 - 2027 (USD Million)
FIG. 59 China downstream processing market, 2016 - 2027 (USD Million)
FIG. 60 India downstream processing market, 2016 - 2027 (USD Million)
FIG. 61 Latin America downstream processing market, 2016 - 2027 (USD Million)
FIG. 62 Brazil downstream processing market, 2016 - 2027 (USD Million)
FIG. 63 Mexico downstream processing market, 2016 - 2027 (USD Million)
FIG. 64 MEA downstream processing market, 2016 - 2027 (USD Million)
FIG. 65 South Africa downstream processing market, 2016 - 2027 (USD Million)
FIG. 66 UAE downstream processing market, 2016 - 2027 (USD Million)
FIG. 67 Strategy framework
FIG. 68 Market participant categorization

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ホルモン補充療法の世界市場:製品別(エストロゲン、人間成長)、投与経路別(経口、非経口)、疾患種類別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆